ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.037,59
0,74%
S&P 500
5.113,38
0,97%
Dow Jones
38.639,83
1,08%
Euro vs US Dollar
1,0781
0,48%
Bitcoin
61.657,07
4,29%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Erytech Pharma SA (ERYP)

  7. Erytech Pharma SA (ERYP) News

ERYP

Erytech Pharma (ERYP)

Erytech Pharma SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ERYP
DatumZeitQuelleÜberschriftSymbolFirma
30/06/202317h33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
29/06/202321h53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ERYPErytech Pharma SA
29/06/202321h52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ERYPErytech Pharma SA
28/06/202314h54Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/06/202314h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
21/06/202312h10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
12/06/202316h34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
24/05/202322h52Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ERYPErytech Pharma SA
24/05/202314h26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
16/05/202316h14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
09/05/202316h30AllPennyStocks.comMicro Cap Bid Up Right Before Opening BellNASDAQ:ERYPErytech Pharma SA
18/04/202314h21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
23/03/202314h38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
14/02/202318h51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
14/02/202312h13Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
23/12/202223h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
22/11/202217h10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
14/10/202212h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
25/08/202219h21Dow Jones NewsErytech Pharma Shares Hit 52-Week Low After Ending Plans for License Application for GraspaNASDAQ:ERYPErytech Pharma SA
25/08/202216h14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/06/202215h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
13/05/202217h37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
02/05/202215h48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
28/04/202214h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
27/04/202218h51Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ERYPErytech Pharma SA
25/04/202222h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
15/03/202214h20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
15/02/202212h30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ERYPErytech Pharma SA
14/02/202219h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
10/02/202214h26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
 Showing the most relevant articles for your search:NASDAQ:ERYP

Kürzlich von Ihnen besucht

CCOM
US500
US 500
TG
RHM
Rheinmetall
NYSE
MRK
Merck
DBI
TDXP
Tec DAX
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
CCOM
US100
US Tech 100
NASDAQ
GOOGL
Alphabet
AMEX
XLF
Financial Select Sector
NASDAQ
NVDA
NVIDIA
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
TG
LHA
Deutsche Lufthansa
NYSE
XOM
Exxon Mobil
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten